Logo
L

Lys Therapeutics

9 employees

Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Life Science
Antibody
Neurology
Parkinson's Disease
Multiple Sclerosis
Health Care
Pharma
Parkinson
Healthcare
Neurovascular diseases
Stroke
Medical
Neurodegenerative disorders
Drug development

Date founded

2021

Funding rounds raised

Total raised

$3.1M

from 1 investors over 1 rounds

L

Lys Therapeutics raised $3.1M on November 14, 2022

Investors: HTH - Health Technologies Holding

FAQ